Bladder Cancer Trial, Recruiting NCT03193515 Sponsor: Cedars-Sinai Medical Center Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT03193515
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People who have been diagnosed with bladder cancer (either the type that has not grown into the muscle wall, or the type that has grown into the muscle wall but was treated without removing the bladder, or has not yet been treated), with the diagnosis made within the past 24 months through a camera examination of the bladder
  • People who have received additional treatment placed directly into the bladder after their main treatment (this is allowed but not required)
  • People who are willing and able to sign a written consent form agreeing to take part
  • People who are willing to attend regular check-up appointments (every 3 months for 2 years for higher-risk cases, or every 6–12 months for 2 years for lower-risk cases)

Who may not be able to join:

  • People who have had their entire bladder surgically removed
  • People who have had another type of cancer (not counting bladder cancer, or certain common skin cancers) within the past 3 years
  • People who currently have an active urinary tract infection or difficulty emptying their bladder
  • People who have active kidney stones or bladder stones, or whose kidneys are not working well enough (based on a blood test result; the blood test must be from within the past 60 days, otherwise a repeat test will be needed)
  • People who have tubes or stents placed in their urinary system or bowel connections to the urinary tract (confirm with trial site)
  • People who have had any procedure or instrument used in their urinary tract within 10 days before signing the consent form
  • People who are unable or unwilling to attend the required follow-up appointments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hideki Furuya, PhD, Cedars-Sinai Medical Center

Phone: 310-423-5609

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Cedars-Sinai Medical Center
Registry
ClinicalTrials.gov
Start date
30 December 2016
Est. completion
1 August 2028

Where this trial is recruiting

🇯🇵 Japan 🇺🇸 United States

Primary endpoints

Sensitivity and specificity of multiplex ELISA assay will be confirmed by cystoscopy.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov